Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States

Abstract excerpt

The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly reduced invasive pneumococcal disease; however, the incidence of nonvaccine serotype invasive disease, particularly due to serotype 19A, has increased. The serotype 19A increase can be explained in part by expansion of a genotype that has been circulating in the US prior to vaccine...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Pneumocystis jirovecii pneumonia detection and treatment
• Share to Pneumonia and Respiratory Infections
• Share to Respiratory viral infections research